Tag: Prescription Drugs
$345 Million Settlement Proposed in EpiPen Lawsuits
Pfizer spokesperson denied any wrongdoing and said settlement was sought to avoid 'the distraction of continued litigation'
High-Dose Buprenorphine Induction in ED Seems Safe for Treating OUD
High-dose buprenorphine protocol well tolerated in patients with untreated opioid use disorder; no reports of respiratory depression or sedation
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease
Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19
For those at high risk, COVID-19-related hospitalization or death from any cause reduced with bamlanivimab/etesevimab versus placebo
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
Overall response, failure-free survival, symptom response significantly greater with ruxolitinib versus control therapy
Two Major Health Systems Will Not Administer Controversial Aduhelm
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
Rx Treatment for Opioid Use Disorder Up Among Medicaid Enrollees
There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Neither Remdesivir Nor HCQ Affect Viral Clearance in COVID-19
No significant difference seen for in-hospital mortality among those receiving remdesivir, hydroxychloroquine, standard of care
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
